Collegium Pharmaceutical
COLL
COLL
248 hedge funds and large institutions have $1.49B invested in Collegium Pharmaceutical in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 102 increasing their positions, 77 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
248
Holders Change
+18
Holders Change %
+7.83%
% of All Funds
3.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
38
Increased
102
Reduced
77
Closed
20
Calls
$2.65M
Puts
$842K
Net Calls
+$1.81M
Net Calls Change
+$374K
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$8.88M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$8.34M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$7.88M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$6.9M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$6.84M |
Top Sellers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$41.9M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$31.6M |
| 3 |
JFG
Jefferies Financial Group
New York
|
-$11.7M |
| 4 |
BlackRock
New York
|
-$10.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$8.51M |
